Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Tylex

Phase 3Small molecule

EEurofarma Laboratorios S.A.

Tylex is one of 30 small molecule programs targeting Dementia. It is currently in Phase 3.

1

Indications

3

Total Trials

1

Active Trials

29

Competitors

Pipeline

Status by Indication[3][1]

Indication

DementiaRecruiting

DementiaPhase 3

Recruiting

Competition

Competitive Landscape

30 competitors in Dementia

#DrugCompanyPhaseTrials

Aricept

Ritalin

Namenda

Exelon

Celexa

Lexapro

Dayvigo

Keppra

Brintellix

Risperdal

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 3Recruiting

Dementia

NCT07323914

Clinical

Trials by Indication[1]

Pain2 trials

A Clinical, Multicenter, Randomized, Parallel-group, Double-blind, Double-dummy, Comparative Study of Non-inferiority of the Fixed Dose Combination of Codeine 30 mg/Dipyrone 500 mg From Eurofarma Versus Tylex® (Codeine 30 mg/Paracetamol 500 mg) in the Treatment of Moderate to Intense Pain Post-impacted Third Lower Molar Extraction

Completed·EEurofarma Laboratorios S.A.·Phase 3·NCT04972292·288 enrolled

A Clinical, Multicenter, Randomized, Parallel-group, Double-dummy, Comparative Study of Non-inferiority of the Fixed-dose Combination of Oxycodone 5 mg/Ibuprofen 400 mg From Eurofarma Versus Tylex® (Codeine 30 mg/Paracetamol 500 mg) in the Treatment of Moderate to Intense Pain Post-impacted Third Lower Molar Extraction

Completed·EEurofarma Laboratorios S.A.·Phase 3·NCT05081102·288 enrolled

Dementia1 trial

Clinical Analgesic Management in Dementia

Recruiting·XXuanwu Hospital, Beijing·Phase 3·NCT07323914·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Tylex. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Tylex compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Tylex. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Eurofarma Laboratorios S.A. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: EEurofarma Laboratorios S.A.

Related News